| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |